Claudia M. Palena

Claudia M. Palena is a renowned oncologist and immunologist known for her significant contributions to the field of cancer immunotherapy. She is currently serving as the Chief of the Immunotherapy Section at the National Cancer Institute (NCI), USA.

Early Life and Education

Claudia M. Palena was born and raised in Argentina. She completed her undergraduate studies in biochemistry at the University of Buenos Aires, Argentina. She then pursued her Ph.D. in molecular biology from the same university.

Career

After completing her Ph.D., Palena moved to the United States and joined the National Cancer Institute (NCI) as a postdoctoral fellow. She later became the Chief of the Immunotherapy Section at NCI. Her research primarily focuses on the development of novel immunotherapeutic strategies for the treatment of metastatic cancer.

Research

Palena's research has significantly contributed to the understanding of the role of tumor microenvironment in cancer progression and metastasis. She has developed novel immunotherapeutic strategies targeting key regulators of epithelial-mesenchymal transition (EMT), a process implicated in cancer metastasis. Her work has led to the identification of new tumor antigens and the development of vaccines and immunotherapies for the treatment of various types of cancer.

Publications

Palena has authored and co-authored numerous peer-reviewed articles in prestigious scientific journals. Her work has been widely cited and has significantly influenced the field of cancer immunotherapy.

Awards and Recognition

Throughout her career, Palena has received several awards and recognition for her contributions to the field of oncology and immunology.

See Also

• Cancer immunotherapy
• National Cancer Institute
• Epithelial-mesenchymal transition